Your browser doesn't support javascript.
loading
A phase I study of pharmacokinetics of trastuzumab emtansine in Chinese patients with locally advanced inoperable or metastatic human epidermal growth factor receptor 2-positive breast cancer who have received prior trastuzumab-based therapy.
Ji, Dongmei; Shen, Weina; Zhang, Jian; Cao, Junning; Li, Wenhua; Lam, Lisa H; Wu, Fan; Wang, Bei; Li, Zao; Sun, Guofang; Hu, Xichun; Chen, Shang-Chiung.
Afiliação
  • Ji D; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Shen W; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Zhang J; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Cao J; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Li W; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Lam LH; Genentech, Inc., South San Francisco, CA, USA.
  • Wu F; Roche (China) Holding Ltd., Shanghai, People's Republic of China.
  • Wang B; Genentech, Inc., South San Francisco, CA, USA.
  • Li Z; Genentech, Inc., South San Francisco, CA, USA.
  • Sun G; Roche (China) Holding Ltd., Shanghai, People's Republic of China.
  • Hu X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Chen SC; Genentech, Inc., South San Francisco, CA, USA.
Medicine (Baltimore) ; 99(44): e22886, 2020 Oct 30.
Article em En | MEDLINE | ID: mdl-33126339

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Trastuzumab Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Trastuzumab Idioma: En Ano de publicação: 2020 Tipo de documento: Article